Mentavi Validates Digital ADHD Diagnostic Pathway
- A new study published in the Journal of Clinical Psychiatry demonstrates the accuracy of Mentavi Health's online diagnostic evaluation for adult ADHD, offering a potential pathway to...
- Mentavi Health announced the publication of its real-world validation study in the Journal of Clinical Psychiatry (JCP) on September 8, 2025.
- The study involved 345 adults seeking web-based ADHD assessment.
“`html
Mentavi Health’s Digital ADHD Diagnosis Validated in Peer-Reviewed Study
Table of Contents
A new study published in the Journal of Clinical Psychiatry demonstrates the accuracy of Mentavi Health’s online diagnostic evaluation for adult ADHD, offering a potential pathway to increased access to care.
What Happened?
Mentavi Health announced the publication of its real-world validation study in the Journal of Clinical Psychiatry (JCP) on September 8, 2025. The study validates the mentavi Diagnostic Evaluation as being as accurate as conventional, in-person clinical interviews for diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. This marks the frist peer-reviewed evidence supporting a fully digital diagnostic pathway for adult ADHD.
Key Findings from the Study
The study involved 345 adults seeking web-based ADHD assessment. Participants were predominantly female, with a mean age of 35. The Mentavi diagnostic Evaluation demonstrated strong diagnostic performance, with a sensitivity of 80.6% and a positive predictive value of 94.9%.
| Metric | Value |
|---|---|
| Sample Size (n) | 345 |
| Mean age | 35 years |
| Sensitivity | 80.6% |
| Positive Predictive Value | 94.9% |
| False Positive Rate | 12% |
| False Positive Rate (In-person Interview) | 56% |
Notably, the false-positive rate for the online tool was substantially lower (12%) compared to traditional in-person clinical interviews (56%). This suggests the Mentavi evaluation is more accurate in correctly identifying individuals *with* ADHD, minimizing misdiagnosis. The full article is freely available via the Journal of Clinical Psychiatry (DOI: [Insert DOI Here]).
Why This Matters: Expanding Access to ADHD Diagnosis
ADHD in adults is often underdiagnosed, with barriers to access including cost, stigma, and limited availability of qualified clinicians. Telehealth solutions like Mentavi’s evaluation have the potential to overcome these barriers, providing a more convenient and affordable pathway to diagnosis and treatment. The validation of this digital tool by a respected peer-reviewed journal lends credibility to the growing field of digital mental health.
Executive Perspectives
“publication in a top-tier peer-review journal moves this evidence base forward,for our diagnostic evaluation specifically and for telehealth in general,” said Barry K. Herman, MD, MMM, Chief Medical Officer at Mentavi health and first author of